Market Cap 1.23B
Revenue (ttm) 0.00
Net Income (ttm) -127.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 366,700
Avg Vol 619,610
Day's Range N/A - N/A
Shares Out 49.36M
Stochastic %K 66%
Beta 1.52
Analysts Strong Sell
Price Target $30.29

Company Profile

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences,...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 312 3013
Address:
Building 23, Suite 105 221 Crescent Street, Waltham, United States
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 15 at 4:27 PM
$JBIO RSI: 80.48, MACD: 1.2312 Vol: 2.13, MA20: 15.59, MA50: 14.92 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BreakoutsHappen
BreakoutsHappen Apr. 15 at 2:16 PM
$JBIO is one of the few names actually working today, pushing higher while most of the tape is flat to red. The move looks flow-driven more than anything else, with volume picking up as the stock grinds higher. These are the types of setups traders tend to focus on intraday — not necessarily because of a major catalyst, but because money is clearly rotating into the name. Biotech continues to be one of the few pockets where you can still get clean moves, and JBIO is a good example of that today. As long as it holds up and doesn’t give back gains too quickly, it stays on the radar. That said, these moves can fade fast. If momentum stalls or volume drops off, it can unwind just as quickly as it went up.
0 · Reply
focafoca99
focafoca99 Apr. 3 at 8:30 PM
$JBIO approved a 2026 inducement equity plan for future new-hire awards.
0 · Reply
kshonstocks
kshonstocks Apr. 1 at 3:31 PM
good early volume $JBIO
1 · Reply
Abron
Abron Mar. 24 at 4:09 PM
$JBIO whats happening? why is the stock falling?
0 · Reply
Abron
Abron Feb. 25 at 4:09 PM
$JBIO every day the same thing
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 19 at 12:29 PM
$JBIO Current Stock Price: $14.44 Contracts to trade: $15.0 JBIO Feb 20 2026 Call Entry: $1.08 Exit: $1.39 ROI: 29% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 12 at 11:27 AM
$JBIO RSI: 40.24, MACD: 0.1000 Vol: 0.83, MA20: 15.49, MA50: 14.88 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
TradeIntelligence_
TradeIntelligence_ Feb. 11 at 12:47 PM
Will $JBIO's conference participation signal a sector rotation? Jade Biosciences announces upcoming presentations. Risk management remains paramount for biotech investors amid shifting market dynamics.
0 · Reply
TrendInsight
TrendInsight Feb. 4 at 3:30 PM
$JBIO is a biotech company; without specifics, it is a high-risk investment dependent on the success of its preclinical or clinical pipeline.
0 · Reply
Latest News on JBIO
Jade Biosciences files $600M mixed securities shelf

2026-05-07T22:32:12.000Z - 5 days ago

Jade Biosciences files $600M mixed securities shelf


Jade Biosciences Appoints Edward R. Conner, M.D.

Apr 22, 2026, 7:00 AM EDT - 21 days ago

Jade Biosciences Appoints Edward R. Conner, M.D.


Jade Biosciences price target raised to $39 from $28 at BTIG

2026-03-16T11:57:55.000Z - 2 months ago

Jade Biosciences price target raised to $39 from $28 at BTIG


Jade Biosciences price target raised to $40 from $19 at Stifel

2026-03-06T17:30:13.000Z - 2 months ago

Jade Biosciences price target raised to $40 from $19 at Stifel


Jade Biosciences reports Q4 EPS ($3.19), consensus ($2.95)

2026-03-06T12:06:42.000Z - 2 months ago

Jade Biosciences reports Q4 EPS ($3.19), consensus ($2.95)


Jade Biosciences to Participate in Upcoming Conferences

Feb 11, 2026, 7:00 AM EST - 3 months ago

Jade Biosciences to Participate in Upcoming Conferences


Jade Biosciences initiated with a Buy at H.C. Wainwright

2026-01-07T11:11:14.000Z - 4 months ago

Jade Biosciences initiated with a Buy at H.C. Wainwright


Jade Biosciences outlines key 2026 objectives, strategy

2026-01-05T12:06:44.000Z - 4 months ago

Jade Biosciences outlines key 2026 objectives, strategy


Jade Biosciences Announces $45 Million Private Placement

Dec 15, 2025, 7:00 AM EST - 5 months ago

Jade Biosciences Announces $45 Million Private Placement


Jade Biosciences initiated with a Buy at Clear Street

2025-11-24T21:36:18.000Z - 6 months ago

Jade Biosciences initiated with a Buy at Clear Street


Jade Biosciences Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 4:00 PM EST - 6 months ago

Jade Biosciences Transcript: Stifel 2025 Healthcare Conference


Jade Biosciences Transcript: Investor Update

Oct 7, 2025, 8:00 AM EDT - 7 months ago

Jade Biosciences Transcript: Investor Update


Jade Biosciences Announces $135 Million Private Placement

Oct 7, 2025, 7:00 AM EDT - 7 months ago

Jade Biosciences Announces $135 Million Private Placement


Jade Biosciences Appoints Brad Dahms as Chief Financial Officer

Jul 1, 2025, 7:00 AM EDT - 11 months ago

Jade Biosciences Appoints Brad Dahms as Chief Financial Officer


Jade Biosciences Transcript: ERA 2025 Conference

Jun 9, 2025, 8:00 AM EDT - 1 year ago

Jade Biosciences Transcript: ERA 2025 Conference


Jade Biosciences Transcript: Jefferies Healthcare Conference

Jun 4, 2025, 12:25 PM EDT - 1 year ago

Jade Biosciences Transcript: Jefferies Healthcare Conference


OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 15 at 4:27 PM
$JBIO RSI: 80.48, MACD: 1.2312 Vol: 2.13, MA20: 15.59, MA50: 14.92 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BreakoutsHappen
BreakoutsHappen Apr. 15 at 2:16 PM
$JBIO is one of the few names actually working today, pushing higher while most of the tape is flat to red. The move looks flow-driven more than anything else, with volume picking up as the stock grinds higher. These are the types of setups traders tend to focus on intraday — not necessarily because of a major catalyst, but because money is clearly rotating into the name. Biotech continues to be one of the few pockets where you can still get clean moves, and JBIO is a good example of that today. As long as it holds up and doesn’t give back gains too quickly, it stays on the radar. That said, these moves can fade fast. If momentum stalls or volume drops off, it can unwind just as quickly as it went up.
0 · Reply
focafoca99
focafoca99 Apr. 3 at 8:30 PM
$JBIO approved a 2026 inducement equity plan for future new-hire awards.
0 · Reply
kshonstocks
kshonstocks Apr. 1 at 3:31 PM
good early volume $JBIO
1 · Reply
Abron
Abron Mar. 24 at 4:09 PM
$JBIO whats happening? why is the stock falling?
0 · Reply
Abron
Abron Feb. 25 at 4:09 PM
$JBIO every day the same thing
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 19 at 12:29 PM
$JBIO Current Stock Price: $14.44 Contracts to trade: $15.0 JBIO Feb 20 2026 Call Entry: $1.08 Exit: $1.39 ROI: 29% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 12 at 11:27 AM
$JBIO RSI: 40.24, MACD: 0.1000 Vol: 0.83, MA20: 15.49, MA50: 14.88 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
TradeIntelligence_
TradeIntelligence_ Feb. 11 at 12:47 PM
Will $JBIO's conference participation signal a sector rotation? Jade Biosciences announces upcoming presentations. Risk management remains paramount for biotech investors amid shifting market dynamics.
0 · Reply
TrendInsight
TrendInsight Feb. 4 at 3:30 PM
$JBIO is a biotech company; without specifics, it is a high-risk investment dependent on the success of its preclinical or clinical pipeline.
0 · Reply
Quantumup
Quantumup Jan. 16 at 6:23 PM
Cantor reiterated Top Pick $VERA Overweight; $100. $TVTX $NVS OTSKY $JBIO VRTX AZN $IONS RHHBY Here's what Cantor had to say: We caught up with VERA, a "Top Pick," and discussed atacicept's (APRIL/BAFF inh; BTD) potential approval in IgA nephropathy (IgAN) and commercial launch preparations... Our overall takeaway is that all the pieces are in place for a successful regulatory outcome as VERA lays the framework for a strong commercial launch.
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 16 at 5:29 PM
$JBIO Current Stock Price: $15.11 Contracts to trade: $15 JBIO Jan 16 2026 Call Entry: $1.13 Exit: $1.56 ROI: 37% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
notreload_ai
notreload_ai Jan. 7 at 3:23 PM
$LEGN , $JBIO , $CGEN ... Oppenheimer and H.C. Wainwright start coverage on Legend Biotech, Jade Biosciences, and Compugen with bullish ratings and price targets, highlighting growth potential in CAR-T therapy, autoimmune, and immuno-oncology pipelines. https://notreload.xyz/oppenheimer-hc-wainwright-bullish-on-leg-jbio-cgen/
0 · Reply
garygb
garygb Jan. 5 at 3:24 PM
$JBIO Like the price better now.
0 · Reply
OGUZATA
OGUZATA Dec. 20 at 11:18 PM
$JBIO It is a critical point, it must be followed carefully moment by moment.
0 · Reply
stayput
stayput Dec. 17 at 4:47 AM
$JBIO Up 32% after reverse split in April. I don’t fold . Avg $12.37. More money will be made imo. Takes some coins to hold imo. NFA
0 · Reply
Trade_Master26
Trade_Master26 Dec. 15 at 11:17 PM
$JBIO perking
0 · Reply